Tech Company Financing Transactions
CRISPR Therapeutics Funding Round
CRISPR Therapeutics secured a $38 million Series B funding round on 6/24/2016. Backers included Bayer, Vertex Pharmaceuticals and Clough Capital Partners.
Transaction Overview
Company Name
Announced On
6/24/2016
Transaction Type
Venture Equity
Amount
$38,000,000
Round
Series B
Investors
Bayer (Lead Investor)
Vertex Pharmaceuticals (Lead Investor)
Proceeds Purpose
Along with the recent investments made by our strategic partners, Vertex and Bayer, we believe this further investment represents a strong validation of our approach to translate the novel CRISPR/Cas9 gene-editing technology into life-changing medicines for patients. We plan to use these proceeds to advance our current and future programs to the clinic and to expand our research and development organization in Cambridge, Massachusetts.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
610 Main St.
Cambridge, MA 02139
USA
Cambridge, MA 02139
USA
Phone
Website
Email Address
Overview
The mission of CRISPR Therapeutics (Nasdaq: CRSP) is to develop transformative gene-based medicines for patients with serious diseases. Our therapeutic approach is to cure diseases at the molecular level using the breakthrough gene editing technology called CRISPR-Cas9.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Samarth Kulkarni
President
Rodger Novak
VP - Bus. Development
Lawrence Klein
VP - General Counsel
James Kasinger
VP - Human Resources
Megan Menner
VP - R & D
Tony Ho
Browse more venture capital transactions:
Prev: 6/24/2016: peerfit venture capital transaction
Next: 6/24/2016: AirXpanders venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on funding rounds that are announced publicly. All VC database entries reported here come from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs